Prof. Srdan Verstovsek - ruxolitinib related anemia management

Prof. dr. Srdan Verstovsek; ruxolitinib related anemia management 

Bewerkt naar presentatie van Prof. dr. Verstovsek tijdens het 2e MPN symposium, dat op 13 maart is gehouden in Utrecht.

 

Referentie:
Verstovsek S, et al. A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med. 2012;366(9):799-807 Appendix
Gupta V. et al. The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies Haematologica. 2016 Dec; 101(12):

 

0419HEM1151436
×

Ask Speakers

×

Medical Information Request